D-0655-2020 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 22, 2020
- Initiation Date
- December 17, 2019
- Termination Date
- October 29, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7 boxes
Product Description
Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX
Reason for Recall
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Distribution Pattern
TX
Code Information
All lots remaining within expiry.